Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Activated Human CD4+CD45RO+ Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling.
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Education attenuates the negative impact of traumatic brain injury on cognitive status.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
Immunotherapy using LPS-stimulated Bone Marrow-derived Dendritic Cells to Treat Experimental Autoimmune Encephalomyelitis.
The Evidence for a Beneficial Role of Vitamin A in Multiple Sclerosis.
The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
Fatigue, depression, and physical impairment in multiple sclerosis.
Targeting cells in motion: migrating toward improved therapies.
Prevalence and Impact of Pain in Adults Aging With a Physical Disability: Comparison to a US General Population Sample.
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
Neuromyelitis optica and pregnancy.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
CD21 positive B cell: A novel target for treatment of multiple sclerosis.
Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
[Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.]
Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy.
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.

Pages